Ipsen SA banner

Intrinsic Value

The intrinsic value of Ipsen SA (IPSEF) under the Base Case is 141.99 USD per share. Compared with the current market price of 113.13 USD, the stock appears Undervalued by 20% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

IPSEF Intrinsic Value
$141.99
Undervaluation 20%
Intrinsic Value
Price $113.13

IPSEF is cheaper than usual. It was this cheap or cheaper on just 17% of days in the past 5 years.

Monitor IPSEF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $113.59
Get notified when the price drops into your buy zone
Intrinsic Value $141.99
Margin of Safety 20% $113.59
Current Price $113.13
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to IPSEF

Fundamental Analysis

What Ipsen Does

Pharmaceuticals Health Care

Ipsen is a French specialty pharmaceutical company that develops and sells prescription medicines for serious diseases, especially in oncology, rare diseases, and certain neurological conditions. Its business is built around branded drugs that doctors prescribe in hospitals and clinics, rather than over-the-counter products.

Headquarters
France FR
Employees
5 535
IPO date
Dec 6, 2005
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Ipsen SA

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

IPN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IPSEF stock?

The intrinsic value for Ipsen SA (IPSEF) under the Base Case is 141.99 USD.

Is IPSEF stock undervalued or overvalued?

Compared with the current market price of 113.13 USD, the stock appears Undervalued by 20% .

Back to Top